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Copyright © 2008 JCBN Summary Effects of astaxanthin (AX) derived from H. pluvialis on human blood rheology
were investigated in 20 adult men with a single-blind method. The experimental group was
57.5 ± 9.8 years of age and the placebo group was 50.8 ± 13.1 years of age. A blood rheology
test that measures whole blood transit time was conducted using heparinized blood of the
volunteers by a MC-FAN apparatus (microchannel array flow analyzer). After administration
of AX 6 mg/day for 10 days, the values of the experimental group were decreased from
52.8 ± 4.9 s to 47.6 ± 4.2 s (p<0.01) and a comparison of the values between the experimental
(47.6 ± 4.2 s) and the placebo (54.2 ± 6.7 s) groups showed a significant difference (p<0.05).
There were no adverse effects resulting from the administration of AX 6 mg/day for 10 days.
Informed consent was obtained from each subject.
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Introduction
Astaxanthin (AX), a form of carotenoid referred to as a
xanthophyll, is a substance distributed widely in nature.
Since being separated from lobster (Astacus gammaus L.)
in 1938 by Kuhn, R. et al. [1], AX has been identified as
the substance composing the red pigmentation in micro-
organisms [2, 3], fish [4], Crustacea [5] and other organisms.
AX is the substance that gives salmon [6] and trout, two
marine products enjoyed as favorite foods in Japan, their
distinct color. Thus many people, especially northern
peoples including Japanese who have long included seafood
in their diets, have been ingesting AX for many years.
While much research concerning the physiological action
of AX has been reported, in research concerning the eyes,
Grangaud, R, et al. [7] have reported on the effect found on
dry eye when AX was administered to rats. Tso, M.O.M.,
et al. [8] have reported AX was found to be effective for eye
damage in rats, and that a recovery effect after application of
optical stress to the eyes was found in a group administered
AX when the thickness of the retina outer granular layer and
rhodopsin decrease were measured and recovery from
damage were compared. In addition, the xanthophyll group
including AX has been reported to protect human eye lens
epithelial cells from UVB-induced stress [9], and AX’s
protective action also has been found to be stronger than that
of α-tocopherol.
As effects of AX ingestion on the eyes, Sawaki et al. [10]
reported improvement in visual acuity for depth and flicker
fusion threshold, while Nagaki, Y. et al. [ 11] reported
significant improvement in amplitude of accommodation
before and after ingestion (no change in amplitude of
accommodation in the control group) in a study employing
VDT workers. Nakamura et al. [12] reported that as a result
of administering 0 mg, 2 mg, 4 mg and 12 mg of AX to four
groups, respectively, once per day for 28 days, there was
improvement in far vision uncorrected visual acuity andH. Miyawaki et al.
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shortened positive accommodation time for the 4 mg group
and 12 mg group, respectively.
In this paper, we report on a study of the effect of AX
ingestion on human blood rheology as one clarification of
the action mechanism for such effects.
Materials and Methods
Study materials and equipment
Study food and placebo food. Study food capsules con-
taining a preparation of AX 3 mg (as a free-form) derived
from  H. pluvialis from Fuji Chemical Industry Co., Ltd.
(FHAX09) and placebo food capsules that did not contain
AX (FHAX10) were used as a study food and placebo food.
Study equipment. Vacuum blood collection tubes
(Terumo) to which 0.25 mL of heparin liquid (Novo
Heparin, 1000 units/ml Aventis Pharma Japan) had been
added beforehand were used to collect 5 ml blood samples
from subjects’ elbow veins, which were used as samples for
the rheology evaluations.
To perform the blood rheology evaluations, heparinized
whole blood samples of approximately 200 μL were forced
to flow through the microchannels of a Microchannel Array
(Bloody 6-7; 8736 channels; width 7 μm, length 30 μm,
depth 4.5 μm; Hitachi Haramachi Electronics Co., Ltd.)
under a pressure difference of 20 cm H2O, and the transit
time for 100 μl of blood was determined using a MC-FAN
(Hitachi Haramachi Electronics Co., Ltd.), in accordance
with the blood rheology procedure described in Kikuchi
et al. [13]. The values obtained were shown by using the
following equation to convert them into the values when the
transit time for 100 μL isotonic saline solution is 12 s, based
on the transit time for isotonic saline solution measured im-
mediately before.
Conversion equation: Converted value = Blood transit time
× 12 s. / Isotonic saline solution transit time
Subjects
The subjects were selected from individuals who had
freely consented to participation in the study in accordance
with the Declaration of Helsinki (individuals who had
signed a consent form). Prior to undertaking the survey, the
physicians in charge of the study handed the participants an
explanation and consent form, and explained all necessary
matters pertaining to the purpose, significance and method
of the study, the anticipated results and risks, the fact the
participant will not suffer any disadvantages if he/she does
not consent to participation in the study, the fact the partici-
pant can withdraw at any time even after having consented
to participation in the study, other related matters, and
protection of the subject’s human rights, and after having
verified the participants had understood the details ex-
plained, obtained consent to voluntary participation in the
study in writing from the participants.
Examinations and measurements were performed at the
first screening. From the subjects determined by the study
physician to be suitable, 20 individuals who showed a stable
blood transit time in a range of 45–70 s/100 μl were selected
at a second screening and made available for the study.
Study method
To create a balance between the two groups based on the
blood transit times measured at the time of the screening
examinations, ten individuals each were allocated to the
study food ingestion group and the placebo food ingestion
group. The subjects were asked to ingest two capsules of the
study food or placebo (AX 6 mg/day or 0 mg/day) once each
day after dinner, and were examined and their blood samples
collected at the start before ingestion and after ten days. For
the blood rheology values immediately prior to ingestion,
the values at the time of the second screening were adopted.
On the day before the day of each visit to the study hospital,
subjects were required to finish dinner by 9:00 PM and
consume no food or beverages (other than water); the
subjects were examined the following morning in a fasting
condition, and blood was collected from a vein in the elbow
area. The daily ingestion amount of 6 mg and ingestion
period of ten days were set based on the results of studies by
Ohno  et al. to set ingestion amount [14] and verify the
results [15].
Evaluation procedure
Mean value and standard deviation were determined for
each evaluation item. The comparison before and after
ingestion was performed by statistical analysis using a
paired t test. In addition, the comparisons between the study
food and placebo were verified for homoscedasticity using
the F test. Student’s t test was performed when the results
were homoscedastic, and the Aspin-Welch t test was
performed when the results were heteroscedastic. The
significance levels were 5% for the F test and 5% and 1%
for the t test.
Results
Preliminary study
To establish the criteria for subject selection for the
blood rheology study, a preliminary study was conducted.
Seven adult males who had consented to participation of
their own free will ingested two AX capsules identical to the
study food once each day (AX 6 mg/day) after dinner for a
ten-day period. Blood transit time measurement was
performed by collecting blood samples, on the morning of
the day ingestion began and on the morning of the day after
the final ingestion day, and measuring transit times. The
results are shown in Table 1. Because a tendency for theEffects of Astaxanthin on Human Blood Rheology
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value to decrease after ingestion was seen for cases in which
the blood rheology values before ingestion were higher than
45 s/100 μl, we decided to select individuals who showed a
value within the 45–70 s/100 μl range for the human blood
rheology measurement study as well.
Human blood rheology measurement study
Subjects’ backgrounds. The subjects’ physical exami-
nation backgrounds are shown in Table 2. At the start of in-
gestion, the subjects had a mean age of 57.5 ± 9.8 years in
the study food ingestion group and 50.8 ± 13.1 years in the
placebo food ingestion group. Body weight, body fat per-
centage, Body Mass Index (BMI), and other measures were
all within normal ranges. As shown by the results, both the
study food ingestion group and the placebo food ingestion
group were structured to have nearly identical subject back-
grounds.
Adverse events and examination opinions. In the physi-
cian examinations implemented on the study food ingestion
start day and after ingestion for ten days, no conditions
corresponding to an adverse event were found. Furthermore,
no anomalies of any kind were found in the subjective
symptom opinions in the ingestion diaries in which the sub-
jects themselves recorded information such as their study
food ingestion circumstances or side effects for each day.
Study food ingestion circumstances and meal question-
naire. The study food ingestion circumstances were 100%
for all subjects. On the meal questionnaire completed on the
screening day, there were no subjects with eating habits that
deserved special mention.
Blood rheology. A summary of the measurement results
for each subjects’ blood transit time measurements is shown
in Table 3 and Fig. 1. Compared with the values before
ingestion, after ingestion for ten days, the blood transit times
for the study food ingestion group were shortened signifi-
cantly (52.8 ± 4.9 s → 47.6 ± 4.2 s). In addition, after inges-
tion for ten days, compared with the placebo food ingestion
group, the study food ingestion group showed significantly
Table 1. Preliminary study blood rheology
Astaxanthin (AX) 6 mg/day; measured before and after ingestion







7 44 37.1 37.8 0.7
5 36 37.6 40.7 3.1
64 8 3 8 . 5 3 8 −0.5
3 48 40.3 42.1 1.8
1 46 45.4 40.7 –4.7
2 60 46.1 43.8 –2.3
4 70 47.7 44.3 –3.4
Table 2. Subjects’ backgrounds
Mean value ± standard deviation
Item Unit Placebo food Study food
Number of subjects Persons 10 10
Age Years 50.8 ± 13.1 57.5 ± 9.8
Height Cm 164.8 ± 5.9 166.5 ± 3.8
Weight Kg 63.41 ± 1.3 66.7 ± 8.5
Body fat percentage % 22.5 ± 5.2 23.9 ± 5.5
BMI — 23.3 ± 3.2 24.0 ± 2.6
Temperature °C 36.1 ± 0.4 35.8 ± 0.4
Table 3. Blood transit time (Unit: Sec/100 μL)
M ± SD: mean value ± standard deviation
Placebo food Study food
Subject No. Ingestion Day 0 Ingestion Day 10 Subject No. Ingestion Day 0 Ingestion Day 10
A01 61.7 57.6 B01 60 53.2
A02 58.9 49.8 B02 57.4 47.5
A03 57 45.7 B03 57 53.4
A04 56.4 49.2 B04 55.7 44.7
A05 55.4 61 B05 54.8 49.2
A06 53.2 57.8 B06 52.3 42.6
A07 49.7 54.7 B07 49 49.5
A08 48.5 66.1 B08 48.4 50.4
A09 48.3 55 B09 47.5 42.8
A10 46.5 45.4 B10 45.4 42.7
M ± SD 53.6 ± 5.1 54.2 ± 6.7 52.8 ± 4.9 47.6 ± 4.2**#H. Miyawaki et al.
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lower values for blood transit time (placebo food ingestion
group: 54.2 ± 6.7 s; study food ingestion group: 47.6 ± 4.2
s). With ingestion of AX 6 mg/day for a ten-day period, the
blood rheology of the study food ingestion group was
improved significantly (p = 0.05) in both a comparison
within the group (Day 0 and Day 10) and a comparison with
the placebo food ingestion group.
Discussion
AX, a form of carotenoid referred to as a xanthophyll,
possesses a chemical structure with the long chain conjugate
double bond and β-ionone ring at both ends that has been
replaced by a keto-group and hydroxyl-group. Since being
separated as a natural pigment with a reddish orange color,
much research has been conducted and its widespread
presence as a pigment in marine products such as shrimp,
crabs, salmon and salmon roe has been clarified. Such fish
and crustaceans are consumed by humans for food, and
considered historically AX is a substance the human race
has ingested from centuries ago. Recently the strong anti-
oxidant effect of AX has attracted attention, and AX is being
tested actively in use as a health food supplement for
maintaining human health. It is believed that micro-
organisms such as algae, yeasts and bacilli utilize AX’s
strong antioxidant effect to defend themselves from strong
natural sunlight, and the fish and crustaceans that consume
these microorganisms also use AX as a pigment because it is
useful in protecting them from the ravages of light and
stress. In addition, AX also is present abundantly in eggs
spawned to produce the next generation, where it is thought
to protect the eggs and be used for the protection and growth
of young fish. While AX is assumed to be one of the sub-
stances with an antioxidant effect found in nature [16, 17]
that shows the strongest antioxidant effect, at this point this
is conjectured from its role in the world of living organisms.
Research in recent years continues to clarify that AX
shows not only an antioxidant effect but various other
physiological actions. On the other hand, as societies evolve
into societies in which people live longer, measures to
prevent the lifestyle diseases that accompany longer lives
also have grown in importance. Ingestion of AX and other
antioxidant substances is likely to be considered as one such
measure. AX demonstrates a variety of physiological actions
and is considered suitable for this purpose.
AX has attracted attention because its action is believed to
work effectively against oxidation in lipid metabolism,
given that AX is said to prevent overoxidation of lipids
through its strong antioxidant effect and have action that
controls oxidation of LDL [18], and also because it is widely
distributed in the lipoprotein areas of the body [19, 20]. Such
actions are though to work by preventing oxidation of
biomembranes including cell membranes, and there is a
possibility this will be linked to effects such as an arterio-
sclerosis prevention effect [21], an anti-inflammatory effect
[22] and control of diabetes nephropathy (kidney disease)
[23, 24].
Furthermore, AX has been reported to have an ocular
accommodation improvement effect [10–15], and the dose
setting study [14] and effect verification study [15] by Ohno
et al. in particular provided results that strongly reconfirm
the effect of AX on ocular accommodation. It is thought
such promotion of recovery from asthenopia in this manner
might contribute to the improvement of blood circulation in
peripheral systems. Based on such conjecture, we performed
a study of the effect of continuous ingestion of AX 6 mg/day
for a ten-day period on blood rheology.
In the study food ingestion group, compared with the
values before ingestion a decrease in blood transit time was
found in eight of ten individuals after ingestion for ten days,
Fig. 1. Summary of measurement results for each subject’s blood transit timeEffects of Astaxanthin on Human Blood Rheology
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and a significant shortening in time was shown for mean
value as well. Moreover, after ingestion for ten days, blood
transit time showed a significantly low value for the study
food ingestion group compared with the placebo food inges-
tion group. A shortening of blood transit time, or in other
words an improvement in blood rheology, was found from
continuously ingesting AX 6 mg per day for ten days.
In the survey of the subjects conducted at the same time,
no abnormal findings or adverse events that appeared to
result from ingestion of the study food were found in the
subjective and objective findings.
Other substances such as tocotrienol, an antioxidant
derived from palm oil [25], and black vinegar [26] (which
has shown antioxidant power) also have been reported
as showing effects for improvement of blood rheology.
Tocotrienol has been found to improve excessive sensitivity
to cold (unpublished data) by improving precapillary
circulation. Based on such reports, the possibility that
improvement of blood rheology improves precapillary
circulation is conjectured. The improvement in blood
rheology from AX is conjectured to confer an antioxidant
effect to the erythrocyte membrane or flexibility to the
membrane, by means such as taking a position that enables it
to traverse longitudinally the suitable membrane to demon-
strate an antioxidant effect within and outside the lipid
double membrane, in contrast to β-carotene, which is
trapped in the lipid double membrane [27] or becomes diffi-
cult to convert into an excellent pro-oxidant for physical
elimination of radicals [28].
Conclusion
We found a shortening of blood transit time—that is, an
improvement of blood rheology—when we studied healthy
adult male volunteers with a blood transit time of 45–70 s
to evaluate the effect on blood rheology from continuous
ingestion of AX 6 mg per day for a ten-day period.
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